$1.58
▲ +0.6% Today
as of Sep 4, 16:47 ET
Last 30 days
Recent Press Releases & News
BofA Adjusts Price Target on Caribou Biosciences to $5 From $6
Caribou Biosciences, Inc. (CRBU) Reports Q2 Loss, Lags Revenue Estimates
Caribou Biosciences Reports Second Quarter 2026 Financial Results and Provides Business Update
Overview
52-week range
$1.38
$3.54
9% of range
Avg surprise (last 3)
+11.2%
Avg reaction (last 2)
+0.2%
50% positive
Latest IV / EM
68%
EM ±8.0% · $2 · Jul 17
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Tue Jun 30, 2026 | Jun 2026 | $-0.24 | — | — | — | — | financials |
| Thu May 7, 2026 | Mar/2026 | $-0.26 | $-0.33 | +21.2% | +39.5% | -3.6% | earnings |
| Tue Sep 30, 2025 | Sep 2025 | $-0.30 | — | — | — | — | financials |
| Tue Aug 12, 2025 | Jun/2025 | $-0.35 | $-0.40 | +12.5% | — | — | earnings |
| Thu May 8, 2025 | Mar/2025 | $-0.43 | $-0.43 | 0.0% | — | +3.9% | earnings |
| Mon Sep 30, 2024 | Sep 2024 | $-0.38 | — | — | — | — | financials |
| Sun Jun 30, 2024 | Jun 2024 | $-0.42 | — | — | — | — | financials |
| Sun Mar 31, 2024 | Mar 2024 | $-0.46 | — | — | — | — | financials |
| Sat Sep 30, 2023 | Sep 2023 | $-0.12 | — | — | — | — | financials |
| Fri Jun 30, 2023 | Jun 2023 | $-0.48 | — | — | — | — | financials |
| Fri Mar 31, 2023 | Mar 2023 | $-0.46 | — | — | — | — | financials |
Financials
Income statement (quarterly)
| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $1M | $2M | — | $2M | $3M | $2M | — | $2M |
| Cost of revenue | — | — | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | $-25M | $-26M | — | $-29M | $-48M | $-43M | — | $-38M |
| Net income | $-24M | $-25M | — | $-28M | $-54M | $-40M | — | $-35M |
| EPS (diluted) | $-0.24 | $-0.26 | — | $-0.30 | $-0.58 | $-0.43 | — | $-0.38 |
Balance sheet (quarterly)
| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $26M | $12M | $12M | $11M | $25M | $29M | $16M | $32M |
| Inventory | — | — | — | — | — | — | — | — |
| Total current assets | $117M | $122M | $145M | $156M | $193M | $217M | $219M | $237M |
| Total assets | $143M | $149M | $175M | $195M | $221M | $274M | $313M | $344M |
| Long-term debt | — | — | — | — | — | — | — | — |
| Total liabilities | $45M | $47M | $53M | $53M | $55M | $56M | $60M | $63M |
| Total equity | $98M | $102M | $122M | $142M | $166M | $217M | $253M | $281M |